Bridging the Gap: Elevating Hispanic Leaders in Central Florida

Pedro Turushina and Dr. Luis Isea
Pedro Turushina, Hispanic Chamber of Metro Orlando president and CEO (left), Dr. Luis Isea, AdventHealth (right)

Explore the importance of Hispanic representation in our community in this episode of the Inspiring Wholeness podcast.

Orange County is around 30% Hispanic and in other surrounding counties that number is higher, according to Pedro Turushina, president and CEO of the Hispanic Chamber of Metro Orlando. Yet less than 5% of the decision-making positions are held by Hispanic leaders. There’s a big gap to help elevate those businesses and professionals to the next level.

In this episode of the Inspiring Wholeness podcast, Turushina joins AdventHealth’s Dr. Luis Isea to share their own career journeys and the importance of Hispanic representation in Central Florida.

Listen to this episode to learn about:

· Health disparities and inequities affecting the Hispanic community and how they might be addressed

· Championing diversity in the health care field, especially within leadership positions

· Free resources the Hispanic Chamber offers businesses and professionals across the region

· Advice for aspiring and emerging Hispanic leaders and entrepreneurs who want to make a difference in the community

Listen now and subscribe so you never miss a new episode.

Recent News

12 items. To interact with these items, press Control-Option-Shift-Right Arrow. These items are in a slider. To advance slider forward, press Shift-Command-Right Arrow. To advance slider backward, press Shift-Command-Left Arrow.
News
New Research Published in New England Journal of Medicine Finds That Adjuvant Pembrolizumab Extends Disease-Free Survival in Muscle-Invasive Urothelial Carcinoma

AdventHealth Clinical Research Unit (CRU) Executive Director and Medical Director of Genitourinary Oncology Guru Sonpavde, MD, co-authored an article on the AMBASSADOR Phase III clinical trial results...

Read Article about "New Research Published in New England Journal of Medicine Finds That Adjuvant Pembrolizumab Extends Disease-Free Survival in Muscle-Invasive Urothelial Carcinoma"
News
AdventHealth for Children Recruiting Patients with Fabry Disease for Phase III PERIDOT Clinical Trial Evaluating a Potential New Treatment Option

Under the leadership of Medical Director of Genomics and Personalized Health Majed Dasouki, MD, AdventHealth for Children is recruiting patients for a new Phase III clinical trial to evaluate the...

Read Article about "AdventHealth for Children Recruiting Patients with Fabry Disease for Phase III PERIDOT Clinical Trial Evaluating a Potential New Treatment Option"
View More Articles